Covaxin’s Second Dose Trial For 2-6 Years Old Children To Start At AIIMS Delhi

New Delhi: The second dose trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, for children between 2-6 years will begin at the All India Institute of Medical Sciences (AIIMS) in New Delhi next week.

According to news agency ANI, the children in the above-mentioned age group have already been inoculated with the first dose of Covaxin.

AIIMS Delhi is a trial centre for the vaccine for those below 18 years. Agency sources also said that Covaxin’s second dose has already been administered to children between 6 and 12 years at AIIMS, Delhi.

The clinical trial results are expected in a month’s time after the completion of trials of all age groups. The trial is being conducted in three phases by segregating children into various age categories.

ALSO READ: Bharat Biotech Dossier Under Review For Covaxin’s Emergency Use Listing: WHO